Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

STRIM

Financiado

Cerrado

Scientific Training for Post-Translational Modification Detection in Cancer Scre...

Scientific Training for Post-Translational Modification Detection in Cancer Screening Cancer remains one of the greatest challenges to the EU healthcare systems. Early detection and diagnosis dramatically increases the prospect of successful treatment and survival. Academia and the rapidly growing cancer diagnostic... ver más

30/09/2028

Presupuesto desconocido

Líder del proyecto

AARHUS UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-10-01

HORIZON-MSCA-2023-DN-01-01: MSCA Doctoral Networks 2023 Expected Outcome:Project results are expected to contribute to the following outcomes:

I+D

Cerrada hace 1 año

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

Participantes

Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

RBCE-GENODIAGNOSENS Recuring breast cancer early genetic diagnostic on a chip 159K€ Cerrado

CanDo A CANcer Development mOnitor 5M€ Cerrado

CanDoIt Intelligent Breast Cancer DiagnOsis and MonItoring Therapeut... Cerrado

FG_WIT AUTOMATED PROTOTYPE OF CANCER DETECTION FROM CTDNA 75K€ Cerrado

MoP-MiP Molecular Programming for MicroRNA profiling 1M€ Cerrado

PROSENSE Cancer Diagnosis Parallel Sensing of Prostate Cancer Biomar... 4M€ Cerrado

Duración del proyecto: 47 meses Fecha Inicio: 2024-10-01
Fecha Fin: 2028-09-30

Líder del proyecto

AARHUS UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Cancer remains one of the greatest challenges to the EU healthcare systems. Early detection and diagnosis dramatically increases the prospect of successful treatment and survival. Academia and the rapidly growing cancer diagnostics and biosensors sectors have an urgent need for researchers skilled in developing improved screening technologies, which can offer major opportunities to impact cancer survival. However, the development of assays with the required sensitivity, reliability and technology formats for multi-cancer early detection is only recently emerging and faces significant R&D challenges.STRIM will train a cohort of researchers in the multi-disciplinary science, bioinformatics, technology, social, clinical and health-economic skills required to deliver comprehensive bioelectronic tools for cancer screening, tools that are fast, accurate, sensitive, and exploit advanced molecular receptors and nanobiotechnologies for detection of aberrant post-translational modifications (PTM) of proteins and nucleic acids as cutting-edge biofluid markers for early detection of cancers. Growing evidence suggests that PTM play important roles in human cancers and are likely to prove highly specific for cancer type. Focusing on both genomic and proteomic PTM biomarkers will be a game-changing strategy for improving early cancer detection rates, efficiency and population health.Doctoral training in STRIM will encompass state-of-the art approaches for ultra-sensitive detection of PTM biomarkers as cancer screening tools by building on recent advances in electrochemiluminescence, aptamer and DNA microarrays and conducting polymer micro-structured electrodes. These techniques will reach new levels of specificity and overcome barriers to the realization of multiplexed diagnostics for enhanced cancer screening. All translational issues will be considered in harmonization with regulatory and health technology assessment and social acceptability will be screened in the population.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores